Dexcom Acquires TypeZero Technologies
TypeZero enhances Dexcom’s offering with tools to simplify diabetes
SAN DIEGO--(BUSINESS WIRE)--Aug. 22, 2018--
the leader in continuous glucose monitoring for people with diabetes,
announced today that it has acquired TypeZero Technologies, Inc.
(“TypeZero”). TypeZero’s offering includes the inControl diabetes
management system, designed to provide personalized diabetes management
solutions including technology to automatically adjust and regulate
Dexcom, TypeZero and the University of Virginia have had a longstanding,
productive relationship in developing important technologies for
diabetes management, including inControl for integration with both
automated insulin delivery (“AID”) and smart pens. The companies share a
consistent vision to improve the lives of people with diabetes through
“As the first iCGM designated by the FDA, Dexcom again has the
opportunity to lead the market for integrated systems for diabetes
management. TypeZero is a great fit for Dexcom as we look to deliver a
growing set of tools to both our insulin delivery partners and our
customers,” said Steve Pacelli, Dexcom’s Executive Vice President of
Strategy & Corporate Development. “Combined with best-in-class CGM
technology, we believe TypeZero’s technology and strong team will
accelerate our efforts to further differentiate Dexcom’s portfolio.”
“The TypeZero team is excited for our next chapter as part of Dexcom,”
said Chad Rogers, TypeZero’s CEO. “For the last several years, our
company has been committed to creating diabetes management products that
simplify the life of a person with diabetes. As part of Dexcom, we will
continue to embrace the mission to empower people with diabetes through
Dexcom currently expects to support the first commercial launch of an
AID system using the inControl algorithm in 2019.
The terms of the transaction were not disclosed.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping
people better manage their diabetes by developing and marketing
continuous glucose monitoring (CGM) systems for use by people with
diabetes and healthcare providers. With exceptional performance, patient
comfort and lifestyle flexibility at the heart of its technology, users
have consistently ranked DexCom highest in customer satisfaction and
loyalty. For more information on the Dexcom CGM, visit www.dexcom.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180822005550/en/
Source: DexCom, Inc.
Steve Pacelli, 858-200-0200